Farther Finance Advisors’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.4K Buy
619
+263
+74% +$6.16K ﹤0.01% 4148
2026
Q1
$5.02K Sell
356
-22
-6% -$296 ﹤0.01% 4492
2025
Q4
$4.25K Buy
378
+220
+139% +$2.52K ﹤0.01% 4394
2025
Q3
$1.83K Sell
158
-190
-55% -$2.23K ﹤0.01% 4170
2025
Q2
$4.26K Buy
348
+151
+77% +$1.9K ﹤0.01% 3423
2025
Q1
$2.83K Buy
197
+163
+479% +$2.54K ﹤0.01% 3255
2024
Q4
$541 Sell
34
-41
-55% -$811 ﹤0.01% 3429
2024
Q3
$1.8K Sell
75
-26
-26% -$594 ﹤0.01% 3031
2024
Q2
$1.99K Buy
101
+60
+146% +$1.17K ﹤0.01% 2797
2024
Q1
$803 Sell
41
-8
-16% -$155 ﹤0.01% 2855
2023
Q4
$1.1K Buy
+49
New +$1.01K ﹤0.01% 2685

Other funds holding AVNS

Farther Finance Advisors's AVNS Position: Q2 2026 in Review

Farther Finance Advisors increased its Avanos Medical (AVNS) stake by 74% in Q2 2026, buying an estimated $6.16K and bringing the position to 619 shares worth $15.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4148.

Farther Finance Advisors first reported a position in AVNS in Q4 2023 and has held it in 11 quarters since. 26 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Farther Finance Advisors held 619 shares of Avanos Medical worth $15.4K as of Q2 2026.
  • Farther Finance Advisors bought 263 Avanos Medical shares in Q2 2026, an estimated $6.16K.
  • Avanos Medical made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4148 holding.
  • Farther Finance Advisors first reported a position in Avanos Medical in Q4 2023 and has held it in 11 quarters since.
  • 26 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.